7th Aug’20 – Jun’20 earnings update on Manappuram and Aarti Drugs

Dear Members, We have released 7th Aug’20 – Jun’20 earnings update on Manappuram Finance and Aarti Drugs. The same has been produced below. For other updates, please refer the following link – Date: 7th Aug’20   Manappuram Finance (NSE – MANAPPURAM) – Jul’17 Alpha stock CMP – 161.60 (BSE); 161.60 (NSE) Rating – Positive – 8% weightage; this is not an investment advice (refer rating interpretation) Source: Manappuram has reported decent set of numbers for Q1 FY 21; however,…

Read More

[Stock idea]: Manappuram Finance – 2nd largest Gold loan NBFC in India

Dear Sir, We have covered Manappuram Finance (NSE Code – MANAPPURAM) for our Premium members. It’s also part of our Model sheet. Since our initial coverage on the stock in Jul’17, the company has witnessed the worst of NBFC crisis in India and has emerged stronger. The company is primarily into short term gold loan business and on the back of positive ALM (asset liability mis-match) it could handle the crisis better. Currently, the company is doing well and unlike…

Read More
Copy Protected by Chetan's WP-Copyprotect.